Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal
  4. Page 2

Federal regulations

Agency
  • DOC231
  • DOT212
  • SEC
201
  • HHS185
  • FDA159
  • DOE146
  • DHS142
  • FERC130
  • FAA96
  • EPA83
  • NOAA76
  • NIH53
  • DOJ51
  • Treasury50
  • USDA47
  • DOL38
  • FCC25
  • SBA23
  • CMS18
  • IRS18
  • HUD17
  • FTC5
  • Topic
    • Compliance11
    • Operations5
    • Government Relations2
    • Administration1
    • Finance1
    • Grant Management1
    • Human Resources1
    • Legal1
    • Marketing1
    • Product Strategy1
    Recency
    • Last 30 days
    • Last 7 days
    DOJRemove filter: DOJFDARemove filter: FDAHHSRemove filter: HHSClear all
    • Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC
      June 17, 2026

      Aphena Pharma Solutions MD, LLC has applied for registration as an importer of basic classes of controlled substances.

    • Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
      June 17, 2026

      AndersonBrecon, Inc. DBA PCI Pharma Services has applied for DEA registration as an importer of controlled substances; supplementary information provides details on specific drug classes.

    • Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
      June 17, 2026

      Wedgewood Pharmacy LLC applied for registration as an importer of controlled substances with the Drug Enforcement Administration.

    • Center for Scientific Review; Amended Notice of Meeting
      June 17, 2026

      Center for Scientific Review amended notice of meeting for the National Institutes of Health scientific review group; meeting details and date available in Federal Register notice.

    • Reducing Bureaucracy and Burden for Human Services and Emergency Response Programs-Repatriation Program
      June 17, 2026

      Final rule eliminates obsolete regulations governing repatriation and care of US nationals returned from foreign countries, streamlining bureaucratic requirements for human services and emergency response programs.

    • Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement With Change to a Previously Approved Collection Title-International Terrorism Victim Expense Reimbursement Program Application
      June 17, 2026

      The Department of Justice's Office of Justice Programs seeks Office of Management and Budget approval to reinstate and modify the International Terrorism Victim Expense Reimbursement Program Application information collection under the Paperwork Red…

    • Center for Scientific Review; Notice of Closed Meetings
      June 16, 2026

      Center for Scientific Review will hold closed meetings to review grant applications and personnel matters; specific dates and locations available upon request to the designated agency contact.

    • Announcement of Solicitation of Written Comments on Proposed Healthy People 2030 Objectives and Request for Information on Screen Time To Inform Healthy People
      June 16, 2026

      HHS Office of Disease Prevention and Health Promotion solicits public comments on proposed Healthy People 2030 objectives and screen time measures to inform national health goals.

    • Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
      June 16, 2026

      Medicare's final rule strengthens oversight of accrediting organizations by addressing conflicts of interest, establishing consistent standards, and updating validation systems for deemed providers and suppliers across multiple care settings.

    • Masuu Global Solutions LLC, U.S. Agent for Extrovis AG, et al.; Withdrawal of Approval of 11 Abbreviated New Drug Applications; Correction
      June 16, 2026

      FDA corrects withdrawal of approval for 11 abbreviated new drug applications; Masuu Global Solutions LLC's propranolol and lidocaine ANDAs remain approved as of March 23, 2026.

    PreviousPage 2 of 34 (336 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Alabama
    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Kentucky
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants